Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

ClinicalTrials.gov ID: NCT03560986

Public ClinicalTrials.gov record NCT03560986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Placebo-controlled Efficacy and Safety Trial of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this trial was to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS). The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A consisting of 4 infusions (neridronic acid 100 mg or placebo) over 10 days, and a Follow-up Period 1 until Week 26. At Week 26, participants meeting the pre-specified criteria entered the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days and follow-up visits until Week 52. Participants not meeting the pre-specified criteria to continue into Treatment Period B continued in Follow-up Period 2 until Week 52.

Study identification

NCT ID
NCT03560986
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Grünenthal GmbH
Industry
Enrollment
267 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2018 (Actual)
Primary completion
Aug 1, 2019 (Actual)
Completion
Aug 1, 2019 (Actual)
Last update posted
Aug 5, 2020

2018 – 2019

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
US446 - Clinical Trial Connection Cottonwood Arizona 86326 —
US453 - Physicians Research Group II, LLC Tempe Arizona 85284 —
US428 - Quality of Life Medical and Research Center LLC Tucson Arizona 85712 —
US422 - Woodland International Research Group Little Rock Arkansas 72211 —
US454 - Alliance Research Institute Canoga Park California 91304 —
US415 - Clearview Medical Research LLC Canyon Country California 91351 —
US410 - Alliance Research Centers Laguna Hills California 92653 —
US432 - Torrance Clinical Research Institute Inc. Lomita California 90717 —
Us414 - Alexander Ford Md Los Angeles California 90035 —
US441 - Samaritan Center for Medical Research Los Gatos California 95032 —
US406 - CI Trials Santa Ana California 92705 —
US411 - Syrentis Clinical Research Santa Ana California 92705 —
US420 - Mountain View Clinical Research, INC Denver Colorado 80209 —
US447 - ASCLEPES Research Centers Brooksville Florida 34613 —
US457 - Florida Spine Institute Clearwater Florida 33765 —
US430 - South Lake Pain Institute Clermont Florida 34711 —
US434 - Finlay Medical Research Miami Florida 33126 —
US407 - Oceane 7 Medical and Research Center, Inc. Miami Florida 33144 —
US436 - Cordova Research Institute Miami Florida 33155 —
US417 - Tampa Pain Relief Center Tampa Florida 33603 —
US403 - Palm Beach Research Center West Palm Beach Florida 33409 —
US404 - Infinite Clinical Trials Riverdale Georgia 30274 —
US424 - Georgia Neurology and Sleep Medicine Assoc. Suwanee Georgia 30024 —
US431 - Injury Care Research, LLC Boise Idaho 83713 —
US437 - Great Lakes Clinical Trials LLC Chicago Illinois 60640 —
US435 - Centex Studies Inc Lake Charles Louisiana 70601 —
US448 - The Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
US450 - SRI International Plymouth Michigan 48170 —
US449 - Michigan Pain Consultants Wyoming Michigan 49503 —
US433 - Creighton University - Osteoporosis Research Center Omaha Nebraska 68122 —
US419 - Manhattan Behavioral Medicine New York New York 10036 —
US440 - OnSite Clinical Solutions LLC Charlotte North Carolina 28210 —
US405 - OnSite Clinical Solutions LLC Hickory North Carolina 28601 —
US416 - Medical Research International Oklahoma City Oklahoma 73109 —
US429 - Lehigh Valley Health Allentown Pennsylvania 18103 —
US438 - Abington Neurological Associates, LTD. Willow Grove Pennsylvania 19090 —
US425 - PCPMG Clinical Research Unit LLC Greenville South Carolina 29601 —
US423 - Biopharma Informatic Inc. Research Center Houston Texas 77043 —
US443 - Centex Studies Inc Houston Texas 77058 —
US421 - Northwest Clinical Research Center Bellevue Washington 98007 —
US445 - Exemplar Research Inc Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03560986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2020 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03560986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →